Bruker Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
BRKR Nasdaq 3840 www.bruker.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bruker Corporation

Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) - Jun 29th, 2026 11:30 am
JPMorgan Maintains an “Overweight rating” on Bruker Corporation (BRKR) - Jun 27th, 2026 9:31 am
Bruker (BRKR) Stock Trades Up, Here Is Why - Jun 25th, 2026 5:13 pm
Bruker Gains 50.3% in a Year: What's Driving the Rally? - Jun 19th, 2026 6:35 am
What Bruker (BRKR)'s Expanded Diagnostics and Energy-Research Tools Portfolio Means For Shareholders - Jun 10th, 2026 1:15 am
Is Bruker Corporation (BRKR) A Good Stock To Buy Now? - Jun 7th, 2026 10:43 am
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam - Jun 6th, 2026 2:02 pm
Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue? - Jun 5th, 2026 9:30 am
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 - Jun 4th, 2026 5:00 am
3 Small-Cap Stocks That Concern Us - Jun 3rd, 2026 10:23 am
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry - Jun 2nd, 2026 9:24 am
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology - Jun 1st, 2026 5:00 am
Q1 Earnings Highs And Lows: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - May 29th, 2026 7:04 am
Is Bruker (BRKR) Quietly Redefining Its Moat With Ultra-High-Field Preclinical MRI Leadership? - May 26th, 2026 3:15 pm
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI - May 26th, 2026 5:00 am
3 Stocks Under $50 with Warning Signs - May 26th, 2026 3:47 am
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down - May 25th, 2026 6:43 am
1 Cash-Producing Stock to Keep an Eye On and 2 We Brush Off - May 18th, 2026 3:08 am
Assessing Whether Bruker (BRKR) Looks Undervalued After Recent Share Price Momentum - May 12th, 2026 2:18 pm
Bruker (BRKR) Q1 2026 Earnings Transcript - May 7th, 2026 11:35 am